ArticleFrontiers in nutrition2026
Dietary index for gut microbiota and odds of gestational diabetes mellitus: associations with inflammatory and metabolic biomarkers.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gestational diabetes mellitus (GDM) is a common metabolic disorder of pregnancy associated with adverse maternal and neonatal outcomes. Emerging evidence suggests that dietary patterns supportive of gut microbial health and associated systemic inflammation may contribute to the pathophysiology of GDM. This study evaluated the association between a dietary index oriented toward gut microbiota (DI-GM)-comprising foods previously linked to beneficial gut microbial composition-and GDM odds, metabolic profiles, inflammatory markers, and pregnancy outcomes. Methods: This case-control study included 800 pregnant women (400 GDM cases and 400 controls) at 24-28 weeks of gestation. Dietary intake was assessed using a validated food frequency questionnaire, and DI-GM scores were derived based on intake of microbiota-supportive and disruptive foods. Biochemical measurements included glucose parameters, lipid profile, hs-CRP, IL-6, TNF- Results: Women with GDM had lower DI-GM scores than controls (7.09 ± 1.64 vs. 9.52 ± 1.83, Conclusion: Greater adherence to a microbiota-oriented dietary pattern was associated with lower GDM odds and improved maternal-neonatal outcomes. However, without direct gut microbiota measurement, these findings represent associations-not confirmation-of diet-microbiota-inflammation pathways, and require further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.